CMPX

Conviction 7HealthcareScan · Thu, Sep 24, 2026

Compass Therapeutics, Inc. (CMPX) closed at $1.14 (-2.99%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 19, RS Rating 7, -83.0% from its 52-week high, -78.0% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

CMPX$1.14-2.99%

ResistanceSupportVol 14

Vol MA14 5.46M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Compass Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.compasstherapeutics.com ↗

Price1.14

Change-2.99%

Gap-0.85%

Rel volume1.36×

Avg volume4.55M

Avg $ vol7.77M

SMA 202.00

SMA 502.10

SMA 2003.75

Price vs 50-45.90%

Price vs 200-69.76%

MA stackbearish

50/200 cross—

Supertrenddown · 1.60

RSI (14)19

MACD hist-0.11

MACD cross—

Stoch %K / %D3 / 4

ADX (14)38

+DI / −DI8 / 48

RSI divergence—

MACD divergence—

ATR %13.09%

ADR %6.17%

52w high6.69

52w low1.14

From 52w high-83.03%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width81.94%

%B-0.03

Donchian pos2.45%

Donchian high2.53

Donchian low1.10

AVWAP (52w high)2.60

vs AVWAP high-56.40%

AVWAP (52w low)1.13

vs AVWAP low+0.29%

OBV trendDown

Chaikin MF (20)-0.20

Today vs 20d1.36×

Avg vol (14d)5.46M

Avg vol (20d)4.55M

Avg $ vol (20d)7.77M

Market cap204.4M

RS Rating7 / 99

RS 3m (vs SPY)-49.66%

RS 6m (vs SPY)-96.14%

RS line new highNo

Trend template0/8

Technical rank1.9

1 week-38.65%

1 month-55.14%

3 months-45.17%

6 months-79.33%

1 year-66.37%

YTD-78.05%

P/E-3.07

P/B1.23

P/S—

P/FCF-4.16

EPS-1.31

Div yield—

ROE-40.04%

ROA-34.96%

Debt/Eq0.00

Current11.22

EV/EBITDA-2.34

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-34.66%

Price target6.13

Target upside440.09%

Analyst ratingBuy

Institutional96.49%

Ent. value168.95M

Revenue0

Net income-25.15M

Gross profit—

Free cash flow-49.17M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out180.09M

Employees39

ListedFri, Nov 13, 2020

Free float96.72M

Float %54.4%

Short interest40.79M

Days to cover17.3d

Short volume44.2%

Squeeze score73 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.13 vs −$0.10

Last surprise-30.0% miss

Setup gradeD

Conviction7 / 100

Pattern quality—

Tech rank1.9 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.54

Support1.83

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CMPX

All disclosures →

No recent disclosed trades by Congress in CMPX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CMPX

Insider	Side	Shares	Value	Traded	Filed
Anderman Jonathan General Counsel · Common Stock · 2026-04-29	Grant	25K	$47K	2026-04-29	2026-04-29
Lerner Neil Chief Accounting Officer · Common Stock · 2026-04-29	Grant	15K	$28K	2026-04-29	2026-04-29

SEC filings

EDGAR filings in CMPX · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

CMPX

Recent news

Get daily signals & real-time alerts.